Indaptus Therapeutics (INDP) announces the appointment of Roger Waltzman, M.D. as its Chief Medical Officer, effective August 7, 2023. Dr. Waltzman joins Indaptus from Molecular Templates (MTEM), a publicly traded biotechnology company focused on discovery and development of immunotoxins.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on INDP: